Catálogo de publicaciones - libros
Título de Acceso Abierto
Recent Advances in Antibody Therapeutics
Resumen/Descripción – provisto por la editorial
No disponible.
Palabras clave – provistas por la editorial
interleukin 33; ST2 receptor; scFv; C2_2E12; bladder cancer; antibodies; immune checkpoint inhibitors; antibody-drug conjugates; sacituzumab govitecan; enfortumab vedotin; erdafitinib; cost-effectiveness; G protein-coupled receptor; membrane protein; antigen; therapeutic antibody; anti-angiogenesis; delta-like ligand; irinotecan; paclitaxel; VEGF; SARS-CoV-2; spike protein; receptor-binding domain; phage display; monoclonal antibody; cytomegalovirus; peptide/major histocompatibility complex class I complex; T-cell-receptor-like antibody; affinity maturation; yeast surface display; combinatorial antibody library; agonist antibody; cell fate; bispecific antibodies; bioassays; mechanisms of action; binding assays; potency assays; atherosclerosis; inflammation; antibody therapy; blood–brain barrier; antibody; pharmacokinetics; disposition; biochemical and physicochemical properties; Fc binding; receptor-mediated transcytosis; brain shuttle; molecular Trojan horse; transferrin; anti-cancer antibody; antibody engineering; biophysical properties; computational methods; research cell bank; antibody therapeutics; recombinant antibodies; intracellular antibodies; single-chain antibody fragment; nanobody; Human papillomaviruses; HPV oncoproteins; HPV-associated cancer; HPV cancer therapy; asthma; refractory asthma; biomarker; n/a
Disponibilidad
Institución detectada | Año de publicación | Navegá | Descargá | Solicitá |
---|---|---|---|---|
No requiere | Directory of Open access Books |
Información
Tipo de recurso:
libros
ISBN electrónico
978-3-0365-4354-3
País de edición
Suiza